Obesity, diabetes mellitus (mostly type 2), and COVID-19 show mutual interactions because
they are not only risk factors for both acute and chronic COVID-19 manifestations, but also …

The global population is currently experiencing the impact of the SARS-CoV-2 coronavirus,
which has caused the Coronavirus Disease 2019 (COVID-19) pandemic. With our profound …

The COVID-19 pandemic has presented a serious challenge to the hepatology community,
particularly healthcare professionals and patients. While the rapid development of safe and …

Background Observational studies have indicated that the incidence of primary biliary
cholangitis (PBC) is higher in inflammatory bowel disease (IBD) patients than that in healthy …

Background Evidence suggests that nonalcoholic fatty liver disease (NAFLD) is associated
with cardiovascular diseases (CVDs). However, the results are inconsistent, and the …

Growing evidence has shown that altered gut microbiota is associated with the
pathogenesis of COVID‐19, but their causal effects are still unclear. We conducted a …

Aim To investigate the potential causal relationship between non‐alcoholic fatty liver
disease (NAFLD) and complications in type 1 diabetes (T1D) and type 2 diabetes (T2D) …

The impact of the coronavirus disease 2019 (COVID-19) pandemic has been immense, and
it continues to have lasting repercussions. While the severe acute respiratory syndrome …

Whole-genome sequencing (WGS) provides a comprehensive view of the genome, enabling
detection of coding and non-coding genetic variation, and surveying complex regions which …

Simple Summary During the COVID-19 pandemic, cancer patients are regarded as a highly
vulnerable population. Given the unavoidable bias and unmeasured confounders in …